158 related articles for article (PubMed ID: 17025245)
1. Evaluation of alternative strategies to optimize ketorolac transdermal delivery.
Puglia C; Filosa R; Peduto A; de Caprariis P; Rizza L; Bonina F; Blasi P
AAPS PharmSciTech; 2006 Aug; 7(3):64. PubMed ID: 17025245
[TBL] [Abstract][Full Text] [Related]
2. Impact of ester promoieties on transdermal delivery of ketorolac.
Liu KS; Hsieh PW; Aljuffali IA; Lin YK; Chang SH; Wang JJ; Fang JY
J Pharm Sci; 2014 Mar; 103(3):974-86. PubMed ID: 24481782
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of Ketorolac ester prodrugs for transdermal delivery.
Doh HJ; Cho WJ; Yong CS; Choi HG; Kim JS; Lee CH; Kim DD
J Pharm Sci; 2003 May; 92(5):1008-17. PubMed ID: 12712420
[TBL] [Abstract][Full Text] [Related]
4. Ketorolac amide prodrugs for transdermal delivery: stability and in vitro rat skin permeation studies.
Kim BY; Doh HJ; Le TN; Cho WJ; Yong CS; Choi HG; Kim JS; Lee CH; Kim DD
Int J Pharm; 2005 Apr; 293(1-2):193-202. PubMed ID: 15778057
[TBL] [Abstract][Full Text] [Related]
5. Ketorolac-dextran conjugates: synthesis, in vitro and in vivo evaluation.
Vyas S; Trivedi P; Chaturvedi SC
Acta Pharm; 2007 Dec; 57(4):441-50. PubMed ID: 18165188
[TBL] [Abstract][Full Text] [Related]
6. Rapid pain relief using transdermal film forming polymeric solution of ketorolac.
Ammar HO; Ghorab M; Mahmoud AA; Makram TS; Ghoneim AM
Pharm Dev Technol; 2013; 18(5):1005-16. PubMed ID: 22191998
[TBL] [Abstract][Full Text] [Related]
7. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
Khurana S; Jain NK; Bedi PM
Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of skin permeation and accumulation profiles of ketorolac fatty esters.
Bhandari KH; Newa M; Yoon SI; Kim JS; Kim DD; Kim JA; Yoo BK; Woo JS; Lyoo WS; Choi JY; Lim HT; Lee JH; Choi HG; Yong CS
J Pharm Pharm Sci; 2007; 10(3):278-87. PubMed ID: 17727791
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of piperazinylalkyl ester prodrugs of ketorolac and their in vitro evaluation for transdermal delivery.
Qandil A; Al-Nabulsi S; Al-Taani B; Tashtoush B
Drug Dev Ind Pharm; 2008 Oct; 34(10):1054-63. PubMed ID: 18608464
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of physicochemical properties, skin permeation and accumulation profiles of ketorolac fatty ester prodrugs.
Bhandari KH; Newa M; Yoon SI; Kim JS; Jang KY; Kim JA; Yoo BK; Woo JS; Lee JH; Kim DD; Choi HG; Yong CS
Biol Pharm Bull; 2007 Nov; 30(11):2211-6. PubMed ID: 17978504
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies.
Ricci M; Puglia C; Bonina F; Di Giovanni C; Giovagnoli S; Rossi C
J Pharm Sci; 2005 May; 94(5):1149-59. PubMed ID: 15793804
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, physicochemical properties and in vitro permeation studies of new ketorolac ester derivatives.
Puglia C; Filosa R; Peduto A; de Caprariis P; Boatto G; Nieddu M; Santagati NA; Bonina F
Curr Drug Deliv; 2007 Jul; 4(3):205-10. PubMed ID: 17627494
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac.
Bonina FP; Puglia C; Barbuzzi T; de Caprariis P; Palagiano F; Rimoli MG; Saija A
Eur J Pharm Sci; 2001 Sep; 14(2):123-34. PubMed ID: 11500258
[TBL] [Abstract][Full Text] [Related]
15. Potential of cyclodextrin complexation and liposomes in topical delivery of ketorolac: in vitro and in vivo evaluation.
Nagarsenker MS; Amin L; Date AA
AAPS PharmSciTech; 2008; 9(4):1165-70. PubMed ID: 19016331
[TBL] [Abstract][Full Text] [Related]
16. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation.
Khurana S; Jain NK; Bedi PM
Drug Dev Ind Pharm; 2015; 41(8):1368-75. PubMed ID: 25151872
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of transdermal apomorphine delivery with a diester prodrug strategy.
Liu KS; Sung KC; Al-Suwayeh SA; Ku MC; Chu CC; Wang JJ; Fang JY
Eur J Pharm Biopharm; 2011 Aug; 78(3):422-31. PubMed ID: 21315820
[TBL] [Abstract][Full Text] [Related]
18. Ester prodrugs of morphine improve transdermal drug delivery: a mechanistic study.
Wang JJ; Sung KC; Huang JF; Yeh CH; Fang JY
J Pharm Pharmacol; 2007 Jul; 59(7):917-25. PubMed ID: 17637185
[TBL] [Abstract][Full Text] [Related]
19. Transdermal delivery of ketorolac.
Amrish C; Kumar SP
Yakugaku Zasshi; 2009 Mar; 129(3):373-9. PubMed ID: 19252396
[TBL] [Abstract][Full Text] [Related]
20. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM
Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
